Category: Ecosystem News

Brickell Biotech Doses First Subject in Phase 1 Study of DYRK1A Inhibitor BBI-02

By: Colorado BioScience Association   Date: 05/19/2022

Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription...

Learn More

AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus

By: Colorado BioScience Association   Date: 05/19/2022

AGC Biologics today announced it is adding viral vector suspension technology and capacity for the development and manufacturing of gene therapies at its commercial-grade campus in Longmont, Col., USA...

Learn More

Weekly Policy Update: Legislative Session Comes to a Close This Week

By: Colorado BioScience Association   Date: 05/09/2022

The legislative session is scheduled to end this Wednesday, May 11th. As we enter these final three days, the CBSA team continues to weigh in on key legislation and advocate on behalf of our life scie...

Learn More

New 450K-square-foot life science campus planned in Broomfield

By: Colorado BioScience Association   Date: 05/04/2022

Developer Scott Caldwell says life science companies needed this space "yesterday." Find out more in the Denver Business Journal article. A rendering of plans for Colorado Research ExchangeLINCOLN PRO...

Learn More

Umoja Biopharma Announces Activation of First ENLIGHTen Phase 1 Trial Site in Study of UB-TT170, a TumorTag that Targets Folate Receptors to Mark Tumors for Clearance by CAR T Cells

By: Colorado BioScience Association   Date: 05/04/2022

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo for patients with solid and hematologic malignancies, announced...

Learn More

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

By: Colorado BioScience Association   Date: 05/04/2022

Brickell Biotech, Inc., a clinical-stage pharmaceutical company striving to transform patient lives by developing innovative and differentiated prescription therapeutics for the treatment of autoimmun...

Learn More

EvoEndo Poised to Transform Clinical Endoscopy Practice with the EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System

By: Colorado BioScience Association   Date: 04/20/2022

EvoEndo®, Inc. (“EvoEndo”), a medical device company which developed a single use system that allows for unsedated Transnasal Endoscopy (TNE), has announced the completion of an $8.4 million Series A...

Learn More

CordenPharma Receives Supplier Recognition Award From Esperion

By: Colorado BioScience Association   Date: 04/15/2022

CordenPharma is honored to announce the receipt of a Supplier Recognition Award from Esperion Therapeutics that was presented by Esperion’s Sr. Vice President of Manufacturing Planning &...

Learn More

Allosource Recognized as the Top Colorado Bioscience Manufacturer

By: Colorado BioScience Association   Date: 04/15/2022

AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products to help surgeons heal their patients, has been recognized as 2022 Bioscience Manufactu...

Learn More

Edgewise-Funded Natural History Trial Of Becker Muscular Dystrophy (BMD) Now Enrolling

By: Colorado BioScience Association   Date: 04/15/2022

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a clinical-stage biopharmaceutical company focused on developing orally bioavailable, small molecule therapies for the treatment of rare muscle disorders, t...

Learn More